Indoco Remedies Limited
ICICI Prudential Mutual Fund bought 6,74,458 shares of Indoco Remedies for ₹13.35 Cr at ₹198.00 apiece in a bulk deal. This was part of a larger transaction where the fund acquired a total of 13,58,002 shares, or a 1.47% stake, in Indoco Remedies across both NSE and BSE for a total deal value of ₹26.88 crore.
A Mumbai-based pharmaceutical company engaged in manufacturing and marketing finished dosage formulations and active pharmaceutical ingredients for domestic and international markets. Indoco Remedies operates across formulations, contract manufacturing, and research divisions, maintaining vertically integrated operations spanning drug development, manufacturing, and distribution. The company serves healthcare providers and patients through its diverse pharmaceutical portfolio and specialized manufacturing capabilities.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.